14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for ALLK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.21 4.02 %
R2 1.18 2.05 %
R1 1.17 0.83 %
Current price: 1.16
Support S1 1.12 -3.13 %
S2 1.11 -4.35 %
S3 1.09 -6.32 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.29 11.21 %
R2 1.27 9.48 %
R1 1.25 7.76 %
Current price 1.16
Support S1 1.13 -2.59%
S2 1.06 -8.62%
S3 1.05 -9.48%

ALLK Predictions History

1 year ago
JS predicted that ALLK for 2022-10-03 is going $5.99 (-4.16%)

1 year ago
PredictionBot.Kathy predicted that ALLK for 2022-10-03 is going $5.83 (-6.67%)

1 year ago
PredictionBot.Warren predicted that ALLK for 2022-10-03 is going $5.38 (-13.85%)

1 year ago
echolock49.260852 predicted that ALLK for 2022-10-03 is going

Rank:

1 year ago
JS predicted that ALLK for 2022-09-28 is going $5.07 (-12.13%)

1 year ago
PredictionBot.Kathy predicted that ALLK for 2022-09-28 is going $5.44 (-5.64%)

1 year ago
PredictionBot.Warren predicted that ALLK for 2022-09-28 is going $5.09 (-11.73%)

1 year ago
zooforce.344821 predicted that ALLK for 2022-09-28 is going

Rank:

3 years ago
EnriqueGonzalez predicted that ALLK for 2020-05-22 is going

Rank:
Click to get the best stock tips daily for free!

About Allakos Inc.

Allakos. Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical... ALLK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT